dEscherichia coli sequence types (STs) 69, 73, 95, and 131 are collectively responsible for a large proportion of E. coli urinary tract and bloodstream infections, and they differ markedly in their antibiotic susceptibilities. Here, we describe a novel PCR method to rapidly detect and distinguish these lineages. Three hundred eighteen published E. coli genomes were compared in order to identify signature sequences unique to each of the four major STs. The specificities of these sequences were assessed in silico by seeking them in an additional 98 genomes. A PCR assay was designed to amplify size-distinguishable fragments unique to the four lineages and was validated using 515 E. coli isolates of known STs. Genome comparisons identified 22 regions ranging in size from 335 bp to 26.5 kb that are unique to one or more of the four predominant E. coli STs, with two to 10 specific regions per ST. These regions predominantly harbor genes encoding hypothetical proteins and are within or adjacent to prophage sequences. Most (13/22) were highly conserved (>96.5% identity) in the genomes of their respective ST. The new assay correctly identified all 142 representatives of the four major STs in the validation set (n ؍ 515), with only two ST12 isolates misidentified as ST95. Compared with MLST, the assay has 100% sensitivity and 99.5% specificity. The rapid identification of major extraintestinal E. coli STs will benefit future epidemiological studies and could be developed to tailor antibiotic therapy to the different susceptibilities of these dominant lineages.
Extraintestinal pathogenic Escherichia coli (ExPEC) strains are frequent pathogens, causing infections spanning a great range of severity (1, 2). They are responsible for 70 to 90% of acute community-acquired uncomplicated urinary infections, 85% of asymptomatic bacteriuria cases, and Ͼ60% of recurrent cystitis infections (3). E. coli is also one of the major pathogens of bloodstream infections, with mortality rates of 10 to 30%; in the United Kingdom, it has been the most common cause of bacteremia in most years since 1990, showing year-on year increases and now accounting for almost one-third of all bacteremias (see www.hpa .org.uk) (4). Successful treatment has been complicated by a rise in the prevalence of antibiotic-resistant strains.DNA profiling, e.g., by multilocus sequence typing (MLST), has advanced our understanding of ExPEC lineages, and several international studies have reported the predominance of sequence types (STs) 69, 73, 95, and 131 among large collections of ExPEC from human infections (5-8). In the United Kingdom, recent regional studies reported the consistent prevalences of these four STs among ExPEC from urinary and bloodstream infections. Collectively, they comprised 45% of the ExPEC strains from community and hospital urine samples recovered in 2007 to 2009 and 2007 to 2008 in Northwest (NW) England and the East Midlands, respectively, as well as 58% of those from bacteremias in northern England in 2010 to 2012 (9-11). The antibiotic ...